Johnson & Johnson EVP Timothy Schmid Exercises Options and Sells $9.23M in Stock

Insider Trading Summary: Johnson & Johnson ($JNJ)

Overview

On September 4, 2026, Johnson & Johnson filed a Form 4 report disclosing that Timothy Schmid, Executive Vice President and Worldwide Chair of MedTech, executed stock option exercises and subsequent open-market sales on September 2, 2026.

Transaction Details

• Option Exercises:
  • Exercised 11,070 options with an exercise price of $131.94 per share.
  • Exercised 22,527 options with an exercise price of $151.41 per share.
  • Total options exercised: 33,597 shares.
• Open-Market Sales:
  • Sold 33,597 shares of Common Stock at an average price of $274.74 per share.
  • Total Gross Proceeds: $9,230,439.78.
• Post-Transaction Direct Holdings: 25,447 shares of Common Stock.
• Indirect Holdings: 758 shares held via 401(k) and 46 shares held via ESOP.

Market Significance

This transaction represents a standard exercise-and-sell execution for employee stock options nearing or within their exercisable window. Because the shares sold were immediately generated from option exercises, the officer's baseline direct equity holding remained steady at 25,447 shares.